{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T04:14:43Z","timestamp":1758946483561},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,6,11]],"date-time":"2010-06-11T00:00:00Z","timestamp":1276214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s11886-010-0125-6","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T09:04:00Z","timestamp":1276160640000},"page":"367-373","source":"Crossref","is-referenced-by-count":6,"title":["Cardiac Resynchronization Therapy in Mild Heart Failure: A Review of the REVERSE and MADIT-CRT Trials"],"prefix":"10.1007","volume":"12","author":[{"given":"Carl R.","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,11]]},"reference":[{"key":"125_CR1","first-page":"e350","volume":"117","author":"AE Epstein","year":"2008","unstructured":"\u2022\u2022 Epstein AE, DiMarco JP, Ellenbogen KA, et al.: ACC\/AHA\/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC\/AHA\/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008, 117:e350\u2013e408. This is the most recent official society guidelines for cardiac device therapy.","journal-title":"Circulation"},{"key":"125_CR2","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.jacc.2009.08.011","volume":"54","author":"C Daubert","year":"2009","unstructured":"\u2022 Daubert C, Gold MR, Abraham WT, et al.: Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J Am Coll Cardiol 2009, 54:1837\u20131846. This is a report of European cohort of REVERSE showing significant difference in the percent worsened in the clinical composite score.","journal-title":"J Am Coll Cardiol"},{"key":"125_CR3","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","volume":"52","author":"C Linde","year":"2008","unstructured":"\u2022\u2022 Linde C, Abraham WT, Gold MR, et al.: Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008, 52:1834\u20131843. This is the main REVERSE trial citation.","journal-title":"J Am Coll Cardiol"},{"key":"125_CR4","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","volume":"361","author":"AJ Moss","year":"2009","unstructured":"\u2022\u2022 Moss AJ, Hall WJ, Cannom DS, et al.: Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009, 361:1329\u20131338. This is the main MADIT-CRT trial citation.","journal-title":"N Engl J Med"},{"key":"125_CR5","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.108.818724","volume":"120","author":"M St John Sutton","year":"2009","unstructured":"\u2022 St John Sutton M, Ghio S, Plappert T, et al.: Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I\/II heart failure. Circulation 2009, 120:1858\u20131865. This is a focused echocardiographic analysis of the REVERSE trial.","journal-title":"Circulation"},{"key":"125_CR6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJM200103223441202","volume":"344","author":"S Cazeau","year":"2001","unstructured":"Cazeau S, Leclercq C, Lavergne T, et al.: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001, 344:873\u2013880.","journal-title":"N Engl J Med"},{"key":"125_CR7","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","volume":"352","author":"JG Cleland","year":"2005","unstructured":"Cleland JG, Daubert JC, Erdmann E, et al.: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352:1539\u20131549. This is a study of 813 NYHA III\/IV HF patients randomized to optimal medical therapy with or without CRT. Mortality was significantly reduced with CRT (20% vs 30%, P < 0.002), and quality-of-life scores, EF, and end-systolic volume index were all improved with CRT.","journal-title":"N Engl J Med"},{"key":"125_CR8","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","volume":"350","author":"MR Bristow","year":"2004","unstructured":"Bristow MR, Saxon LA, Boehmer J, et al.: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350:2140\u20132150.","journal-title":"N Engl J Med"},{"key":"125_CR9","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1161\/01.CIR.0000146336.92331.D1","volume":"110","author":"WT Abraham","year":"2004","unstructured":"Abraham WT, Young JB, Leon AR, et al.: Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004, 110:2864\u20132868.","journal-title":"Circulation"},{"key":"125_CR10","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0735-1097(03)01042-8","volume":"42","author":"SL Higgins","year":"2003","unstructured":"Higgins SL, Hummel JD, Niazi IK, et al.: Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003, 42:1454\u20131459.","journal-title":"J Am Coll Cardiol"},{"key":"125_CR11","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1056\/NEJMoa0706695","volume":"357","author":"JF Beshai","year":"2007","unstructured":"\u2022 Beshai JF, Grimm RA, Nagueh SF, et al.: Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 2007, 357:2461\u20132471. This is an important negative result in a trial of 172 patients with narrow QRS but moderate to severe HF. Echocardiography was used to identify mechanical dyssynchrony. No significant difference was found in peak VO 2 with CRT, providing evidence against use of CRT in HF patients and narrow QRS (RETHINQ).","journal-title":"N Engl J Med"},{"key":"125_CR12","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1161\/CIRCULATIONAHA.107.743120","volume":"117","author":"ES Chung","year":"2008","unstructured":"Chung ES, Leon AR, Tavazzi L, et al.: Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008,117:2608\u20132616.","journal-title":"Circulation"},{"key":"125_CR13","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jacc.2007.06.043","volume":"50","author":"J Gorcsan 3rd","year":"2007","unstructured":"Gorcsan J 3rd, Tanabe M, Bleeker GB, et al.: Combined longitudinal and radial dyssynchrony predicts ventricular response after resynchronization therapy. J Am Coll Cardiol 2007, 50:1476\u20131483.","journal-title":"J Am Coll Cardiol"},{"key":"125_CR14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.echo.2008.01.003","volume":"21","author":"J Gorcsan 3rd","year":"2008","unstructured":"Gorcsan J 3rd, Abraham T, Agler DA, et al.: Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting\u2014a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr 2008, 21:191\u2013213.","journal-title":"J Am Soc Echocardiogr"},{"key":"125_CR15","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/CIRCULATIONAHA.105.571455","volume":"113","author":"MS Suffoletto","year":"2006","unstructured":"Suffoletto MS, Dohi K, Cannesson M, et al.: Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation 2006, 113:960\u2013968.","journal-title":"Circulation"},{"key":"125_CR16","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.jacc.2006.07.067","volume":"48","author":"GB Bleeker","year":"2006","unstructured":"Bleeker GB, Holman ER, Steendijk P, et al.: Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol 2006, 48:2243\u20132250.","journal-title":"J Am Coll Cardiol"},{"key":"125_CR17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.amjcard.2006.07.068","volume":"99","author":"GB Bleeker","year":"2007","unstructured":"Bleeker GB, Schalij MJ, Boersma E, et al.: Relative merits of M-mode echocardiography and tissue Doppler imaging for prediction of response to cardiac resynchronization therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2007, 99:68\u201374.","journal-title":"Am J Cardiol"},{"key":"125_CR18","first-page":"A135","volume":"53","author":"MR Gold","year":"2009","unstructured":"Gold MR, Linde C, Lozano IF, et al.: Relationship of QRS duration to reverse remodeling with cardiac resynchronization therapy in mild heart failure: results from the resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) trial. J Am Coll Cardiol 2009, 53:A135.","journal-title":"J Am Coll Cardiol"},{"key":"125_CR19","first-page":"S814","volume":"120","author":"MR Gold","year":"2009","unstructured":"Gold MR, Linde C, Lozano IF, et al.: Impact of QRS duration on clinical response with cardiac resynchronization therapy: results from the REVERSE trial [abstract]. Circulation 2009, 120:S814.","journal-title":"Circulation"},{"key":"125_CR20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.amjcard.2006.01.080","volume":"98","author":"GB Bleeker","year":"2006","unstructured":"Bleeker GB, Schalij MJ, Holman ER, et al.: Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol 2006, 98:230\u2013235.","journal-title":"Am J Cardiol"},{"key":"125_CR21","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.106.620039","volume":"114","author":"H Skali","year":"2006","unstructured":"Skali H, Pfeffer MA, Lubsen J, Solomon SD: Variable impact of combining fatal and nonfatal end points in heart failure trials. Circulation 2006, 114:2298\u20132303.","journal-title":"Circulation"},{"key":"125_CR22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1054\/jcaf.2001.25652","volume":"7","author":"M Packer","year":"2001","unstructured":"Packer M: Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail 2001, 7:176\u2013182.","journal-title":"J Card Fail"},{"key":"125_CR23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10840-007-9170-5","volume":"21","author":"WH Sauer","year":"2008","unstructured":"Sauer WH, Bristow MR: The Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial in perspective. J Interv Card Electrophysiol 2008, 21:3\u201311.","journal-title":"J Interv Card Electrophysiol"},{"key":"125_CR24","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/CIRCULATIONAHA.105.538272","volume":"112","author":"CM Yu","year":"2005","unstructured":"Yu CM, Bleeker GB, Fung JW, et al.: Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005, 112:1580\u20131586.","journal-title":"Circulation"},{"key":"125_CR25","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/eurheartj\/ehl099","volume":"27","author":"JG Cleland","year":"2006","unstructured":"Cleland JG, Daubert JC, Erdmann E, et al.: Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 2006, 27:1928\u20131932.","journal-title":"Eur Heart J"},{"key":"125_CR26","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa013168","volume":"346","author":"WT Abraham","year":"2002","unstructured":"Abraham WT, Fisher WG, Smith AL, et al.: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002, 346:1845\u20131853.","journal-title":"N Engl J Med"},{"key":"125_CR27","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.jacc.2009.08.013","volume":"54","author":"DV Exner","year":"2009","unstructured":"Exner DV: Is it time to expand the use of cardiac resynchronization therapy to patients with mildly symptomatic heart failure? J Am Coll Cardiol 2009, 54:1847\u20131849.","journal-title":"J Am Coll Cardiol"},{"key":"125_CR28","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMe0907335","volume":"361","author":"M Jessup","year":"2009","unstructured":"Jessup M: MADIT-CRT\u2014breathtaking or time to catch our breath? N Engl J Med 2009, 361:1394\u20131396.","journal-title":"N Engl J Med"},{"key":"125_CR29","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.CIR.0000085166.44904.79","volume":"108","author":"TJ Wang","year":"2003","unstructured":"Wang TJ, Evans JC, Benjamin EJ, et al.: Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003, 108:977\u2013982.","journal-title":"Circulation"},{"key":"125_CR30","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.106.666818","volume":"115","author":"KA Ammar","year":"2007","unstructured":"Ammar KA, Jacobsen SJ, Mahoney DW, et al.: Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology\/American Heart Association heart failure staging criteria in the community. Circulation 2007, 115:1563\u20131570.","journal-title":"Circulation"},{"key":"125_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HCO.0b013e32831bc63b","volume":"24","author":"AS Tang","year":"2009","unstructured":"Tang AS, Wells GA, Arnold M, et al.: Resynchronization\/defibrillation for ambulatory heart failure trial: rationale and trial design. Curr Opin Cardiol 2009, 24:1\u20138.","journal-title":"Curr Opin Cardiol"},{"key":"125_CR32","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1540-8167.2005.50062.x","volume":"16","author":"RN Doshi","year":"2005","unstructured":"Doshi RN, Daoud EG, Fellows C, et al.: Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 2005, 16:1160\u20131165.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"125_CR33","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1001\/jama.288.24.3115","volume":"288","author":"BL Wilkoff","year":"2002","unstructured":"Wilkoff BL, Cook JR, Epstein AE, et al.: Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002, 288:3115\u2013123.","journal-title":"JAMA"},{"key":"125_CR34","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1540-8167.2007.00907.x","volume":"18","author":"AB Curtis","year":"2007","unstructured":"Curtis AB, Adamson PB, Chung E, et al.: Biventricular versus right ventricular pacing in patients with AV block (BLOCK HF): clinical study design and rationale. J Cardiovasc Electrophysiol 2007, 18:965\u2013971.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"125_CR35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/europace\/eul075","volume":"8","author":"RC Funck","year":"2006","unstructured":"Funck RC, Blanc JJ, Mueller HH, et al.: Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the \u2018Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)\u2019 study. Europace 2006, 8:629\u2013635.","journal-title":"Europace"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-010-0125-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-010-0125-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-010-0125-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:56:14Z","timestamp":1559433374000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-010-0125-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,11]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["125"],"URL":"https:\/\/doi.org\/10.1007\/s11886-010-0125-6","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,11]]}}}